{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:22:05Z","timestamp":1789590125961,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejphar.2019.05.031","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:23:04Z","timestamp":1558063384000},"page":"172402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment"],"prefix":"10.1016","volume":"856","author":[{"given":"Narjes","family":"Hendouei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Saghafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Shadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-8036","authenticated-orcid":false,"given":"Seyed Jalal","family":"Hosseinimehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.05.031_bib1","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1158\/0008-5472.CAN-03-2329","article-title":"Sigma receptors and cancer: possible involvement of ion channels","volume":"64","author":"Aydar","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3748\/wjg.v22.i7.2159","article-title":"Pharmacological cyclin dependent kinase inhibitors: implications for colorectal cancer","volume":"22","author":"Balakrishnan","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1535-7163.11.3.1","article-title":"Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines","volume":"3","author":"Barton","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.05.031_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S1461145706006857","article-title":"Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs","volume":"10","author":"Beaulieu","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib5","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.05.031_bib6","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.3892\/ol.2017.6815","article-title":"Combining thioridazine and loratadine for the treatment of gastrointestinal tumor","volume":"14","author":"Chen","year":"2017","journal-title":"Oncology lett"},{"key":"10.1016\/j.ejphar.2019.05.031_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2019.05.031_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00210-004-0961-2","article-title":"Antiproliferative and cytotoxic effects of some \u03c3 2 agonists and \u03c3 1 antagonists in tumour cell lines","volume":"370","author":"Colabufo","year":"2004","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0006-291X(84)80352-6","article-title":"Chlorpromazine: a potential anticancer agent?","volume":"125","author":"Darkin","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2019.05.031_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2017.01.042","article-title":"A chemical genomics approach to drug reprofiling in oncology: antipsychotic drug risperidone as a potential adenocarcinoma treatment","volume":"393","author":"Dilly","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.05.031_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2019.05.031_bib13","doi-asserted-by":"crossref","first-page":"111728","DOI":"10.18632\/oncotarget.22904","article-title":"Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.05.031_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1535-7163.MCT-17-0090","article-title":"A CRISPR\/Cas9-Based screening for non-homologous end joining inhibitors reveals ouabain and penfluridol as radiosensitizers","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.05.031_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/cancers8030035","article-title":"Mechanisms of nuclear export in cancer and resistance to chemotherapy","volume":"8","author":"El-Tanani","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2019.05.031_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA oncology"},{"key":"10.1016\/j.ejphar.2019.05.031_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review","volume":"79","author":"Fond","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2019.05.031_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004068","article-title":"Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data","volume":"11","author":"Fortney","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib19","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.05.031_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.05.031_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mrgentox.2007.05.011","article-title":"Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair","volume":"633","author":"Gangopadhyay","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0973-1482.19585","article-title":"Potential of radiosensitizing agents in cancer chemo-radiotherapy","volume":"1","author":"Girdhani","year":"2005","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ejphar.2019.05.031_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/carcin\/24.3.435","article-title":"Cyclin D1 over-expression correlates with \u03b2-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3\u03b2 and ERK1\/2 in mouse hepatic carcinogenesis","volume":"24","author":"Gotoh","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2019.05.031_bib24","doi-asserted-by":"crossref","first-page":"37389","DOI":"10.1074\/jbc.M111.287433","article-title":"IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase\/PDK1\/mTORC2 and the pleckstrin homology domain to sustain malignant transformation","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib25","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.surg.2012.05.014","article-title":"Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands","volume":"152","author":"Hornick","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.ejphar.2019.05.031_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.drudis.2007.07.017","article-title":"Trends in the development of radioprotective agents","volume":"12","author":"Hosseinimehr","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2019.05.031_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrm.2016.27","article-title":"Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases","volume":"17","author":"Hydbring","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib28","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.05.031_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/dna.2017.3790","article-title":"Trifluoperazine activates FOXO1-related signals to inhibit tumor growth in hepatocellular carcinoma","volume":"36","author":"Jiang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib30","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/cam4.506","article-title":"Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance","volume":"4","author":"Jotte","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejphar.2019.05.031_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1476-5381.2010.00923.x","article-title":"Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines","volume":"161","author":"Kast","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.05.031_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2012.10.002","article-title":"Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells","volume":"91","author":"Kim","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.05.031_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245602","article-title":"Mechanisms of action of atypical antipsychotic drugs: a critical analysis","volume":"124","author":"Kinon","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2019.05.031_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.it.2004.12.003","article-title":"Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy","volume":"26","author":"Klebanoff","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib36","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2174\/1389450110607011377","article-title":"Glycogen synthase kinase-3-an overview of an over-achieving protein kinase","volume":"7","author":"Kockeritz","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2019.05.031_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bjc.2016.19","article-title":"Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve","volume":"114","author":"Koukourakis","year":"2016","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2019.05.031_bib38","article-title":"Anti-psychotic drugs regulate Hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels","volume":"110","author":"Lauth","year":"2010","journal-title":"Molecular pharmacology, mol"},{"key":"10.1016\/j.ejphar.2019.05.031_bib39","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib40","doi-asserted-by":"crossref","first-page":"27580","DOI":"10.18632\/oncotarget.4768","article-title":"Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.05.031_bib41","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/sj.onc.1201867","article-title":"Mutant p53 protein expression interferes with p53-independent apoptotic pathways","volume":"16","author":"Li","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.05.031_bib42","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In vivo regulation of glycogen synthase kinase-3\u03b2 (GSK3\u03b2) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2019.05.031_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1471-4159.2005.03079.x","article-title":"Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells","volume":"93","author":"Lieb","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1789.2008.00911.x","article-title":"The activation of ERK1\/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification","volume":"28","author":"Lopez-Gines","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.ejphar.2019.05.031_bib45","first-page":"1543","article-title":"Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis","volume":"8","author":"Lu","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2019.05.031_bib46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.bjp.0705936","article-title":"Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines","volume":"143","author":"Mahe","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib47","first-page":"6146595","article-title":"Role of natural radiosensitizers and cancer cell radioresistance: an update","author":"Malik","year":"2016","journal-title":"Anal. Cell Pathol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2010.10.012","article-title":"Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(\u00b1)-MRJF4] in prostate cancer cells","volume":"46","author":"Marrazzo","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib49","first-page":"316","article-title":"Evaluation of breast self-examination program using Health Belief Model in female students","volume":"16","author":"Moodi","year":"2011","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.ejphar.2019.05.031_bib50","first-page":"459","article-title":"New biological properties of neuroleptic phenothiazines","volume":"23","author":"Morak-M\u0142odawska","year":"2007","journal-title":"Pol. Merkur. Lek.: organ Polskiego Towarzystwa Lekarskiego"},{"key":"10.1016\/j.ejphar.2019.05.031_bib51","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/or.2014.3068","article-title":"Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer","volume":"31","author":"Mu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2019.05.031_bib52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/00498254.2014.901585","article-title":"Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole","volume":"44","author":"Nagasaka","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2019.05.031_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-4159.2009.05897.x","article-title":"Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival","volume":"109","author":"Niizuma","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib54","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.6b01039","article-title":"Antiangiogenic Effect of (\u00b1)-haloperidol metabolite ii valproate ester [(\u00b1)-MRJF22] in human microvascular retinal endothelial cells","volume":"59","author":"Olivieri","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib55","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","article-title":"Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma","volume":"65","author":"Ormandy","year":"2005","journal-title":"J. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00210-015-1144-z","article-title":"Effect of thioridazine on antioxidant status of HEMn-DP melanocytes","volume":"388","author":"Otr\u0119ba","year":"2015","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1247\/csf.13012","article-title":"The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic \u03b2 cells by blocking PERK-mediated translational attenuation","volume":"38","author":"Ozasa","year":"2013","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ejphar.2019.05.031_bib58","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.05.031_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10822-014-9811-6","article-title":"Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study","volume":"29","author":"Patil","year":"2015","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejphar.2019.05.031_bib60","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/1535-7163.MCT-06-0402","article-title":"The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non\u2013small cell lung carcinoma cells to DNA double-strand break\u2013induced cell death","volume":"6","author":"Polischouk","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.05.031_bib61","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1176\/appi.ajp.2013.13050650","article-title":"Antipsychotic treatment in breast cancer patients","volume":"171","author":"Rahman","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.05.031_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705517","article-title":"Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer","volume":"39","author":"Ranjan","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib63","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple negative breast cancer by inhibiting integrin signaling axis","volume":"76","author":"Ranjan","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib64","doi-asserted-by":"crossref","first-page":"32960","DOI":"10.18632\/oncotarget.16515","article-title":"Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1","volume":"8","author":"Ranjan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.05.031_bib65","doi-asserted-by":"crossref","first-page":"47632","DOI":"10.18632\/oncotarget.17425","article-title":"Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth","volume":"8","author":"Ranjan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.05.031_bib66","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.05.031_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.drudis.2016.02.019","article-title":"The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers","volume":"21","author":"Salehifar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2019.05.031_bib68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1389203711314020005","article-title":"Essential role of Gli proteins in glioblastoma multiforme","volume":"14","author":"Santoni","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejphar.2019.05.031_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.05.031_bib70","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.05.031_bib71","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-12-1542","article-title":"Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy","volume":"19","author":"Selvakumaran","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1006353008903","article-title":"Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials","volume":"17","author":"Senderowicz","year":"1999","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ejphar.2019.05.031_bib73","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.3390\/ijms150610034","article-title":"Cytotoxic autophagy in cancer therapy","volume":"15","author":"Sharma","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.05.031_bib74","article-title":"In silico identification and in vitro and in vivo validation of anti-psychotic drug fluspirilene as a potential CDK2 inhibitor and a candidate anti-cancer drug","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.05.031_bib75","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.cellsig.2006.02.004","article-title":"Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+\/calmodulin in PTEN-negative U-87MG human glioblastoma cells","volume":"18","author":"Shin","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2019.05.031_bib76","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Shin","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2019.05.031_bib77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/0008-5472.CAN-09-3663","article-title":"Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity","volume":"70","author":"Sottoriva","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-1426-2-3","article-title":"Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment","volume":"2","author":"Spranger","year":"2014","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejphar.2019.05.031_bib80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006046604062","article-title":"The cell death response to \u03b3-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide","volume":"51","author":"Strobl","year":"1998","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.05.031_bib81","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1101\/lm.1067808","article-title":"Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex","volume":"15","author":"Sui","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2019.05.031_bib82","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.21873\/anticanres.11085","article-title":"Aripiprazole, an antipsychotic and partial dopamine agonist, inhibits cancer stem cells and reverses chemoresistance","volume":"36","author":"Suzuki","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3835(99)00020-8","article-title":"Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo","volume":"139","author":"Szab\u00f3","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.05.031_bib84","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.bbamem.2014.08.022","article-title":"Potential applications for sigma receptor ligands in cancer diagnosis and therapy","volume":"1848","author":"van Waarde","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.05.031_bib85","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib86","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10549-015-3290-x","article-title":"Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-\u03baB signaling pathways","volume":"149","author":"Wang","year":"2015","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.05.031_bib87","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein","volume":"103","author":"Wang","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib88","doi-asserted-by":"crossref","first-page":"37511","DOI":"10.18632\/oncotarget.16400","article-title":"Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.05.031_bib89","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF00254251","article-title":"Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13","volume":"11","author":"Wei","year":"1983","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.031_bib90","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.05.031_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-015-0276-9","article-title":"Molecular targeted therapy for the treatment of gastric cancer","volume":"35","author":"Xu","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-016-0303-5","article-title":"Targeting autophagy to sensitive glioma to temozolomide treatment","volume":"35","author":"Yan","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib93","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.05.031_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098805","article-title":"Combination treatment of tamoxifen with risperidone in breast cancer","volume":"9","author":"Yeh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.05.031_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-017-0588-z","article-title":"Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.05.031_bib96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:30Z","timestamp":1757975250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919303450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":96,"alternative-id":["S0014299919303450"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.05.031","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172402"}}